Cited by 695Sleep and related disordersObstructive Sleep Apnea ResearchAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Prevalence, burden, and treatment of insomnia in primary care

Gregory E. Simon, Michael VonKorff·1997·American Journal of Psychiatry

DOI 10.1176/ajp.154.10.1417

Open this paper in CoChat — free account

Abstract

OBJECTIVE: The prevalence, burden, and management of insomnia among primary care patients were evaluated. METHOD: Consecutive patients aged 18 to 65 years in primary care clinics of a staff-model health maintenance organization (N = 1,962) were screened with the 12-item General Health Questionnaire. A stratified random sample (N = 373) completed face-to-face diagnostic assessments including the Composite International Diagnostic Interview, a brief self-rated disability questionnaire (Brief Disability Questionnaire), and the interviewer-rated Social Disability Schedule. A telephone follow-up survey was completed 3 months later. Use of psychotropic drugs, use of mental health services, and direct health care costs were assessed by using the health plan's automated data systems. RESULTS: Approximately 10% of the primary care patients reported major current insomnia (e.g., taking at least 2 hours to fall asleep nearly every night). Current insomnia was associated with significantly greater functional impairment (according to both Brief Disability Questionnaire and Social Disability Schedule), more days of disability due to health problems, and greater general medical service utilization. While insomnia was associated with depressive disorder and chronic medical illness, adjustment for these factors only partially accounted for the association of insomnia with disability and with health care utilization. Of the patients with current insomnia, 28% received any psychotropic drug; 14% received benzodiazepines and 19% received antidepressants. CONCLUSIONS: Insomnia among primary care patients is associated with greater functional impairment, lost productivity, and excess health care utilization.

Integrity signals

Registry

Crossref · 10.1176/ajp.154.10.1417

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Risk Factors for Falls among Elderly Persons Living in the Community
Tinetti, M. E., Speechley, M. R., & Ginter, S. F. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812293192604 · Cited by 6,615
The MOS Short-form General Health Survey: Reliability and Validity in a Patient Population
Stewart, A. L., Hays, R. D., & Ware, J. E. (1988) · Medical Care · doi:10.1097/00005650-198807000-00007 · Cited by 3,339
The Composite International Diagnostic Interview: An Epidemiologic Instrument Suitable for Use in Conjunction With Different Diagnostic Systems and in Different Cultures
Robins, L. N. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360017003 · Cited by 2,909
The functioning and well-being of depressed patients. Results from the Medical Outcomes Study
Wells, K. B. (1989) · JAMA · doi:10.1001/jama.262.7.914 · Cited by 2,826
Epidemiologic Study of Sleep Disturbances and Psychiatric Disorders: An Opportunity for Prevention?
Ford, D. E. (1989) · JAMA · doi:10.1001/jama.1989.03430110069030 · Cited by 2,252
The Functioning and Well-being of Depressed Patients: Results From the Medical Outcomes Study
Wells, K. B. (1989) · JAMA · doi:10.1001/jama.1989.03430070062031 · Cited by 2,130 · cited 2×
“This figure is comparable to the excess disability associated with lung disease or diabetes seen in the Medical Outcomes Study (23).”
Result
Insomnia and Its Treatment: Prevalence and Correlates
Mellinger, G. D. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790260019002 · Cited by 1,071
Psychotropic Drug Use and the Risk of Hip Fracture
Ray, W. A., Griffin, M. R., Schaffner, W., Baugh, D. K., & Melton, L. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160702 · Cited by 1,006
A chronic disease score from automated pharmacy data
Korff, M. V., Wagner, E. H., & Saunders, K. W. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90016-g · Cited by 962
Prevalence of sleep disorders in the Los Angeles metropolitan area
Bixler, E. O., Kales, A., Soldatos, C. R., Kales, J. D., & Healey, S. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.10.1257 · Cited by 889

Show all 29 references

Research works printed but not linked: 4

Goldberg DP, 1988, England
Saunders K, 1994, Pharmacoepidemiology, 171
Cochran W, 1977, Sampling Techniques
Simon G, 1995, Mental Illness in General Health Care: An International Study. Edited by Üstün T, Sartorius N., 265

Sorted by citations

Items 201–300 of 695

Patient characteristics and patterns of drug use for sleep complaints in the united states: Analysis of national ambulatory medical survey data, 1997–2002
Morlock, R., Tan, M. L., & Mitchell, D. Y. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.07.008 · Cited by 64
Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo‐controlled study
Braam, W., Didden, R., Smits, M. G., & Curfs, L. (2007) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2007.01016.x · Cited by 62
Excessive Daytime Sleepiness is Associated with Increased Health Care Utilization Among Patients Referred for Assessment of OSA
Ronksley, P. E., Hemmelgarn, B. R., Heitman, S. J., Ward, F. W., Ghali, W. A., Manns, B., Faris, P., & Tsai, W. H. (2011) · SLEEP · doi:10.1093/sleep/34.3.363 · Cited by 62
Bright light treatment of depression for older adults [ISRCTN55452501]
Loving, R. T., Kripke, D. F., Elliott, J. A., Knickerbocker, N. C., & Grandner, M. A. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-41 · Cited by 61
“Background Several reviews have emphasized the enormous socioeconomic impact in elders of insomnia and depression which are often intertwined [1-5].”
Background
Overview of Insomnia: Definitions, Epidemiology, Differential Diagnosis, and Assessment
Edinger, J. D., & Means, M. K. (2005) · Elsevier eBooks · doi:10.1016/b0-72-160797-7/50066-5 · Cited by 62
Effects of restless legs syndrome (RLS) on sleep
Bogan, R. (2006) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2006.2.4.513 · Cited by 60
Does self‐efficacy mediate the relationship between transformational leadership behaviours and healthcare workers’ sleep quality? A longitudinal study
Munir, F., & Nielsen, K. M. (2009) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2009.05039.x · Cited by 60
Sleep Habits, Insomnia, and Daytime Sleepiness in a Large and Healthy Community-Based Sample of New Zealanders
Wilsmore, B. R., Grunstein, R. R., Fransen, M., Woodward, M., Norton, R., & Ameratunga, S. N. (2013) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.2750 · Cited by 59
“Sleep quantity < 1 full night sleep per week 791 (4) 1 to 6 full nights sleep per week 15,788 (74) > 6 full nights sleep per week 4,730 (22)”
Association of Statin Use with Sleep Disturbances: Data Mining of a Spontaneous Reporting Database and a Prescription Database
Takada, M., Fujimoto, M., Yamazaki, K., Takamoto, M., & Hosomi, K. (2014) · Drug Safety · doi:10.1007/s40264-014-0163-x · Cited by 59
Untitled work
(2006) · Cited by 58
Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement
Montplaisir, J. Y., Hawa, R., Moller, H. J., Morin, C. M., Fortin, M., Matte, J., Reinish, L. W., & Shapiro, C. M. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.445 · Cited by 59
Acute inescapable stress exposure induces long-term sleep disturbances and avoidance behavior: a mouse model of post-traumatic stress disorder (PTSD)
Philbert, J., Pichat, P., Beeské, S., Decobert, M., Belzung, C., & Griebel, G. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.02.039 · Cited by 57
Quetiapine for primary insomnia: a double blind, randomized controlled trial.
Tassniyom, K., Paholpak, S., Tassniyom, S., & Kiewyoo, J. (2010) · PubMed · Cited by 57
Sleep Disturbances and Inflammatory Bowel Disease
Ali, T., & Orr, W. C. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000108 · Cited by 56
The Nature of Insomnia and the Need to Refine Our Diagnostic Criteria
Morin, C. M. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200007000-00005 · Cited by 56
“It is often associated with functional impairments, reduced quality of life, and significant health care costs (1).”
Background
Workaholism and Sleep Quality Among Japanese Employees: A Prospective Cohort Study
Kubota, K., Shimazu, A., Kawakami, N., & Takahashi, M. (2012) · International Journal of Behavioral Medicine · doi:10.1007/s12529-012-9286-6 · Cited by 55
“In modern industrialized society, poor sleep is prevalent [23, 24]; its consequences include functional impairments, reduced quality of life, and significant healthcare costs [25].”
Background
The Relationship between Sensory Processing Patterns and Sleep Quality in Healthy Adults
Engel‐Yeger, B., & Shochat, T. (2012) · Canadian Journal of Occupational Therapy · doi:10.2182/cjot.2012.79.3.2 · Cited by 68
“Poor sleep impairs con-centration, memory, interpersonal relationships, and mood (Roth & AncoliIsrael, 1999; Walsh, 2004) and may lead to health problems such as depression (Simon & Vonkorff, 1997).”
Background
Declining Sleep Quality among Nurses: A Population-Based Four-Year Longitudinal Study on the Transition from Nursing Education to Working Life
Hasson, D., & Gustavsson, P. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014265 · Cited by 62
“Previous studies estimate the prevalence of poor sleep in the general population to be between 10–30% [34,36,37,38,39].”
Background
BASELINE DEPRESSION LEVELS DO NOT AFFECT EFFICACY OF COGNITIVE-BEHAVIORAL SELF-HELP TREATMENT FOR INSOMNIA
Lancee, J., van den Bout, J., van Straten, A., & Spoormaker, V. I. (2012) · Depression and Anxiety · doi:10.1002/da.22004 · Cited by 53
“[2–4] Insomnia is associated with psychological problems such as anxiety and depression.”
Background
Role of acupuncture in the treatment of insomnia: A comprehensive review
Kalavapalli, R., & Singareddy, R. K. (2007) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2007.01.001 · Cited by 53
The Emperor’s New Drugs: Medication and Placebo in the Treatment of Depression
Kirsch, I. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44519-8_16 · Cited by 55
Cognitive behavior therapy for chronic insomnia
Smith, M. T., & Neubauer, D. N. (2003) · Clinical cornerstone · doi:10.1016/s1098-3597(03)90033-0 · Cited by 54
Main effects of sleep disorders related to shift work—opportunities for preventive programs
Bajraktarov, S., Novotni, A., Manusheva, N., Nikovska, D. G., Miceva-Velickovska, E., Zdraveska, N., Samardjiska, V. C., & Richter, K. S. (2011) · The EPMA Journal · doi:10.1007/s13167-011-0128-4 · Cited by 52
Hypnotic Medications: Mechanisms of Action and Pharmacologic Effects
Mendelson, W. B. (2005) · Elsevier eBooks · doi:10.1016/b0-72-160797-7/50043-4 · Cited by 52
Psychological and Behavioral Treatments for Primary Insomnia
Morin, C. M. (2005) · Elsevier eBooks · doi:10.1016/b0-72-160797-7/50068-9 · Cited by 52
Do sleep complaints contribute to age-related cognitive decline?
Altena, E., Ramautar, J. R., van der Werf, Y. D., & Someren, E. J. W. V. (2010) · Progress in brain research · doi:10.1016/b978-0-444-53702-7.00011-7 · Cited by 51
“Days spent in bed due to illness are about twice as common among insomniacs compared to noninsomniacs, even after correcting for age, gender and chronic disease (Simon and VonKorff, 1997).”
Background
Spontaneous adverse event reports associated with zolpidem in Australia 2001-2008
BEN-HAMOU, M., Marshall, N. S., Grunstein, R. R., Saini, B., & Fois, R. A. (2011) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2011.00919.x · Cited by 51
“Prevalence estimates depend on the definition of impairment and the duration of the affliction (Simon and Vonkorff, 1997), but the disorder is nearly universally experienced over some part of the lifespan.”
Background
The influence of job stress, social support and health status on intermittent and chronic sleep disturbance: an 8-year longitudinal analysis
Gosling, J. A., Batterham, P. J., Glozier, N., & Christensen, H. M. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.04.007 · Cited by 52
“Aside from causing significant distress and disease burden [3], sleep disturbance is a risk factor of both physical and mental disorders, including diabetes [4], coronary artery disease [5] and increased mortality in general [6,7], whilst mental health problems for which sleep disturbance elevates risk most commonly i…”
Background
Determinants of sleep problems in patients with spondyloarthropathy
Costa, D. D., Zummer, M., & Fitzcharles, M. (2009) · Musculoskeletal Care · doi:10.1002/msc.155 · Cited by 51
“, 2005), symptom amplifi cation (Haack and Mullington, 2005), greater functional disability (Katz and McHorney, 2002), more work absenteeism (Kuppermann et al., 1995; Simon and VonKorff, 1997) and more healthcare utilization (Hatoum et al.”
Background
Predisposition in the Evolution of Insomnia: Evidence, Potential Mechanisms, and Future Directions
Drake, C. L., & Roth, T. G. (2006) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2006.06.005 · Cited by 53
“comparable to that of patients who have other chronic medical conditions [13,14].”
Result
Sleep and Residual Sedation After Administration of Zaleplon, Zolpidem, and Placebo During Experimental Middle-of-the-Night Awakening
Zammit, G. K., Corser, B. C., Doghramji, K., Fry, J. M., JAMES, S. P., Krystal, A. D., & Mangano, R. M. (2006) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26657 · Cited by 51
A Polysomnographic Placebo-Controlled Evaluation of the Efficacy and Safety of Eszopiclone Relative to Placebo and Zolpidem in the Treatment of Primary Insomnia
Erman, M. K., Zammit, G. K., Rubens, R., Schaefer, K., Wessel, T. C., Amato, D. A., Caron, J., & Walsh, J. K. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27185 · Cited by 50
“Other objectives were to: (1) assess the hypnotic efficacy of zolpidem 10 mg relative to placebo, (2) evaluate the safety of eszopiclone compared with placebo and zolpidem 10 mg, (3) assess the effect of treatment on the daytime symptoms of insomnia, and (4) make qualitative comparisons among the 5 drug conditions.”
Background
Insomniac complaints interfere with quality of life but not with absenteeism: Respective role of depressive and organic comorbidity
Philip, P., Léger, D., Taillard, J., Quera-Salva, M.-A., Niedhammer, I., Jasso-Mosqueda, J. G., Bioulac, B. H., & Gérard, D. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2006.04.006 · Cited by 50
“In addition, they generally understand that insomnia has an impact on quality of life (QoL) [4,11].”
BackgroundResult
‘Young old’ and ‘old old’ poor sleepers with and without insomnia complaints
McCrae, C. S., Wilson, N. M., Lichstein, K. L., Durrence, H. H., Taylor, D. J., Bush, A. J., & Riedel, B. W. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00543-3 · Cited by 50
“Because insomnia is associated with significant healthcare costs and morbidity [8–12], it represents a major health threat for the elderly.”
Background
Quality Measures for the Care of Patients with Insomnia
Edinger, J. D., Buysse, D. J., Deriy, L. V., Germain, A., Lewin, D. S., Ong, J. C., & Morgenthaler, T. I. (2015) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.4552 · Cited by 51
Use of benzodiazepine drugs and perceived job stress in a cohort of working men and women in Belgium. Results from the BELSTRESS-study
Pelfrene, E., Vlerick, P., Moreau, M., Mak, R. P., Kornitzer, M., & Backer, G. D. (2003) · Social Science & Medicine · doi:10.1016/j.socscimed.2003.11.002 · Cited by 48
Insomnia and Its Effective Non-pharmacologic Treatment
Siebern, A. T., & Manber, R. (2010) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.02.005 · Cited by 51
“Specifically, those with insomnia had significantly higher total health services costs than those without.(23)”
Background
Psychometric Testing and Validation of the Chronic Pain Sleep Inventory
Kosinski, M. R., Janagap, C. C., Gajria, K., & Schein, J. R. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.12.001 · Cited by 47
Partner-assisted cognitive behavioural therapy for insomnia versus cognitive behavioural therapy for insomnia: a randomised controlled trial
Mellor, A., Hamill, K., Jenkins, M. M., Baucom, D. H., Norton, P. J., & Drummond, S. P. A. (2019) · Trials · doi:10.1186/s13063-019-3334-3 · Cited by 51
Comorbid insomnia, psychological symptoms and widespread pain among patients suffering from musculoskeletal pain in general practice: a cross-sectional study
Sørensen, L., Jensen, M. S. A., Rathleff, M., & Holden, S. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031971 · Cited by 31
Sleeping Disorders in Early Chronic Kidney Disease
DESANTO, R. (2006) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2005.06.014 · Cited by 47
Sleep Disturbances and Their Management in Patients with Brain Injury
Thaxton, L., & Myers, M. A. (2002) · Journal of Head Trauma Rehabilitation · doi:10.1097/00001199-200208000-00007 · Cited by 47
Prevalence, Types and Possible Causes of Insomnia in a Swiss Remand Prison
Elger, B. S. (2004) · European Journal of Epidemiology · doi:10.1023/b:ejep.0000036805.58237.e3 · Cited by 47
“, taking at least 2 hours to fall asleep nearly every day for 2 weeks) was used, a prevalence of only 10% was reported [25].”
Method
Anxiety sensitivity: predictor of sleep-related impairment and medication use in chronic insomnia
Vincent, N., & Walker, J. (2001) · Depression and Anxiety · doi:10.1002/da.1073 · Cited by 46
Why Treat Insomnia?
Perlis, M. L., Pigeon, W. R., Grandner, M. A., Bishop, T. M., Riemann, D. W., Ellis, J. G., Teel, J., & Posner, D. A. (2021) · Journal of Primary Care & Community Health · doi:10.1177/21501327211014084 · Cited by 49
Sleep in Mood Disorders
Peterson, M. J., & Benca, R. M. (2008) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2008.01.009 · Cited by 50
Behavioral treatment of insomnia: a proposal for a stepped-care approach to promote public health
Rybarczyk, B. D., & Mack, L. (2011) · Nature and Science of Sleep · doi:10.2147/nss.s12975 · Cited by 46
“Individuals who complain of sleep disturbance are more likely to use the health care system.(8,9) Walsh and Engelhardt(10) estimate that the total direct US domestic cost of insomnia was US$13.”
Background
Home-Based Video CBT for Comorbid Geriatric Insomnia: A Pilot Study Using Secondary Data Analyses
Rybarczyk, B. D., Lopez, M., Schelble, K., & Stepanski, E. J. (2005) · Behavioral Sleep Medicine · doi:10.1207/s15402010bsm0303_4 · Cited by 46
“This hypothesis was based on studies showing that insomniawasan independentpredictorofqualityof life in individualswithchronic illness (Katz & McHorney, 1998; Simon & VonKorff, 1997).”
Method
Rational and targeted pharmacologic treatment of fibromyalgia
Barkhuizen, A. (2002) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(01)00011-4 · Cited by 46
“Pharmacologic agents include pure sedatives acting on benzodiazepine receptors, sedating antihistamines and sedating antidepressants [115].”
Background
A Quantitative Approach to Distinguishing Older Adults with Insomnia from Good Sleeper Controls
Levenson, J. C., Troxel, W., Begley, A. E., Hall, M. H., Germain, A., Monk, T. H., & Buysse, D. J. (2013) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.2404 · Cited by 45
“11,12 Insomnia is accompanied by signifi cant individual and societal cost 13 and is associated with greater healthcare utilization, greater impairment, 10,14 and an increased risk of comorbid medical and psychiatric conditions.”
Comparison of Lorazepam and Zopiclone for Insomnia in Patients with Stroke and Brain Injury
Shan, R. S. L. P., & Ashworth, N. L. (2004) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/00002060-200406000-00003 · Cited by 45
“Insomnia has also been associated with increased healthcare costs and social disability.(5) Hypnotics are often prescribed to improve restfulness so that patients may be more productive during the day.”
Background
Sleep Complaints and Incident Disability in a Community-Based Cohort Study of Older Persons
Park, M. M., Buchman, A. S., Lim, A. S. P., Leurgans, S. E., & Bennett, D. A. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.12.023 · Cited by 44
“(5-15) While cross-sectional studies have demonstrated the association between sleep complaints and functional impairment (16-18), including disability (19), there are a paucity of studies which have examined whether sleep complaints predict the subsequent development of disability.”
Background
Cost Effectiveness of Long-Term Treatment with Eszopiclone for Primary Insomnia in Adults
Botteman, M. F., Ozminkowski, R. J., Wang, S. S., Pashos, C. L., Schaefer, K., & Foley, D. J. (2007) · CNS Drugs · doi:10.2165/00023210-200721040-00005 · Cited by 43
Subtypes of Sleep Disturbance: Associations Among Symptoms, Comorbidities, Treatment, and Medical Costs
Foley, K. A., Sarsour, K., Kalsekar, A., & Walsh, J. K. (2010) · Behavioral Sleep Medicine · doi:10.1080/15402001003622842 · Cited by 44
“Therefore, it is not surprising that sleep complaints are more common among patient populations than in the general population (Katz & McHorney, 1998; Simon & VonKorff, 1997; Terzanoa et al., 2004).”
Background
Understanding sleep disturbances in African‐American breast cancer survivors: a pilot study
Taylor, T. R., Huntley, E. D., Makambi, K. H., Sween, J., Adams-Campbell, L. L., Frederick, W., & Mellman, T. A. (2011) · Psycho-Oncology · doi:10.1002/pon.2000 · Cited by 46
“In addition, sleep problems are a significant burden among patients in terms of functional impairment and reduced quality of life [4].”
Prevalence and factors associated with off-label antidepressant prescriptions for insomnia
Lai, L., Tan, M. H., & Lai, Y.-C. (2011) · Drug, Healthcare and Patient Safety · doi:10.2147/dhps.s21079 · Cited by 46
“21,22 Wiegand postulated that physicians favor antidepressants over FDA-approved benzodiazepines due to uninformed perceptions of the safety and nonaddictive advantages of antidepressants over benzodiazepine receptor agonists.”
Development of a Just-in-Time Adaptive mHealth Intervention for Insomnia: Usability Study
Pulantara, I. W., Parmanto, B., & Germain, A. (2018) · JMIR Human Factors · doi:10.2196/humanfactors.8905 · Cited by 43
“Diagnostic rates of insomnia however—based on criteria from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) —range between 5%-20% in the general adult population [4] and 20%-30% in primary care medical settings [5,6].”
Method
Prevalence of self-reported sleep disturbance among older adults and the association of disturbed sleep with service demand and medical conditions
Blay, S. L., Andreoli, S. B., & Gastal, F. L. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207006308 · Cited by 41
“In recent years, few studies have assessed the hypothesis that sleep disturbance is associated with more frequent utilization of health services in adult samples (Simon and VonKorff, 1997; Novak et al., 2004; Gilmer et al., 2005).”
Background
Psychosocial Correlates of Insomnia Severity in Primary Care
Bluestein, D. A., Rutledge, C., & Healey, A. C. (2010) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2010.02.090179 · Cited by 41
Prevalence of Reported Insomnia and its Consequences in a Survey of 5,044 Adolescents in Kuwait
Abdel‐Khalek, A. M. (2004) · SLEEP · doi:10.1093/sleep/27.4.726 · Cited by 41
“This procedure is consistent with earlier studies that considered the selection of the options “Always” or “Often” as an indication that the subject has the problem.(27,29,37,38)”
Result
Effects of Some H1-Antagonists on the Sleep-Wake Cycle in Sleep-Disturbed Rats
Tokunaga, S., Takeda, Y., Shinomiya, K., Hirase, M., & Kamei, C. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0061173 · Cited by 40
Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty
Mini, L. J., Wang‐Weigand, S., & Zhang, J. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.09.004 · Cited by 40
Cardiovascular Complications of Sleep Disorders: A Better Night’s Sleep for a Healthier Heart / From Bench to Bedside
Manolis, T. A., Manolis, A. S., Apostolopoulos, E. J., Melita, H., & Manolis, A. S. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200325102411 · Cited by 42
Chronic insomnia: Recent advances and innovations in treatment developments and dissemination.
Morin, C. M. (2010) · Canadian Psychology/Psychologie canadienne · doi:10.1037/a0018715 · Cited by 39
Cognitive Behavioral Therapy for Insomnia in Older Adults
Bélanger, L., LeBlanc, M., & Morin, C. M. (2011) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2010.10.003 · Cited by 39
“Significant and chronic insomnia, on the other hand, produces negative consequences for the individual and is typically associated with increased daytime fatigue, mood disturbances, and cognitive problems that contribute to reduced quality of life (Simon & VonKorff, 1997).”
Chronic Painful Physical Conditions, Disturbed Sleep and Psychiatric Morbidity: Results from an Elderly Survey
Blay, S. L., Andreoli, S. B., & Gastal, F. L. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701468099 · Cited by 39
Identifying Cases of Sleep Disorders through International Classification of Diseases (ICD) Codes in Administrative Data
Jolley, R., Liang, Z., Peng, M., Pendharkar, S. R., Tsai, W. H., Chen, G., Eastwood, C. A., Quan, H., & Ronksley, P. E. (2018) · International Journal for Population Data Science · doi:10.23889/ijpds.v3i1.448 · Cited by 39
“Estimates of the prevalence of chronic insomnia vary depending on the criteria used and population studied but have been reported to be from 10% to as high as 40%(10-15).”
Background
Do symptoms of depression, anxiety or stress impair the effectiveness of cognitive behavioural therapy for insomnia? A chart-review of 455 patients with chronic insomnia
Sweetman, A., Lovato, N., Micic, G., Scott, H., Bickley, K., Haycock, J., Harris, J. K., Gradisar, M., & Lack, L. C. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.08.023 · Cited by 40
The assessment and management of insomnia in primary care
Falloon, K., Arroll, B., Elley, C., & Fernando, A. (2011) · British medical journal · doi:10.1136/bmj.d2899 · Cited by 42
Sleep Disorders and Increased Risk of Subsequent Acute Coronary Syndrome in Individuals without Sleep Apnea: A Nationwide Population-Based Cohort Study
Chung, W., Lin, C., Chen, Y., Chiang, J. Y., Sung, F.-C., Chang, Y.-J., & Kao, C. (2013) · SLEEP · doi:10.5665/sleep.3240 · Cited by 38
Co‐occurring depression and insomnia in Australian primary care: recent scientific evidence
Sweetman, A., Lack, L. C., Ryswyk, E. V., Vakulin, A., Reed, R. L., Battersby, M., Lovato, N., & Adams, R. (2021) · The Medical Journal of Australia · doi:10.5694/mja2.51200 · Cited by 39
Sleep Locus of Control: Report on a New Scale
Vincent, N., Sande, G., Read, C. N., & Giannuzzi, T. (2004) · Behavioural Sleep Medicine · doi:10.1207/s15402010bsm0202_1 · Cited by 39
“…experience persistent sleep problems, leading to the development of fatigue, reduced concentration and memory, absenteeism, increased errors and accidents, and various other health care problems (Roth & Ancoli-Israel, 1999; Shochat, Umphress, Israel, & Ancoli-Israel, 1999; Simon & VonKorff, 1997).”
Background
Concordance of Sleep and Pain Outcomes of Diverse Interventions: An Umbrella Review
Doufas, A. G., Panagiotou, O. A., & Ioannidis, J. P. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040891 · Cited by 37
“Approximately 10% of patients seen in primary care report major insomnia [7] and sleep disturbances exist in 50–89% [8–10] or more [11,12] patients with chronic pain.”
Background
Sleep Difficulties and Insomnia Symptoms in Norwegian Musicians Compared to the General Population and Workforce
Vaag, J. R., Saksvik‐Lehouillier, I., Bjø‌rngaard, J. H., & Bjerkeset, O. A. (2015) · Behavioral Sleep Medicine · doi:10.1080/15402002.2015.1007991 · Cited by 37
“…a link between insomnia and decreased concentration, difficulties performing duties, work-related accidents, decreased job performance, and work absenteeism (Kessler et al., 2012; Léger, Guilleminault, Bader, Lévy, & Paillard, 2002; Miriam Kuppermann & Mazonson, 1995; Simon & VonKorff, 1997).”
Background
Predicting Treatment Response in Older Adults with Insomnia
Gagné, A., & Morin, C. M. (2001) · Journal of Clinical Geropsychology · doi:10.1023/a:1009537722740 · Cited by 37
Insomnia and hypnotic use in Campo Grande general population, Brazil
Souza, J. C., Magna, L. A., & Reimão, R. (2002) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2002000500003 · Cited by 37
Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: A trial from the University of Rochester Cancer Center Community Clinical Oncology Program
Palesh, O. G., Mustian, K. M., Peppone, L. J., Janelsins, M. C., Sprod, L. K., Kesler, S. R., Innominato, P. F., Roth, T. G., Manber, R., Heckler, C. E., et al. (2012) · Sleep Medicine · doi:10.1016/j.sleep.2012.06.001 · Cited by 37
“In the general population, sleep problems are associated with significant impairments in quality of life [7], almost a two-fold increase in accidents [8], increased days spent in bed, and decreased activity [9].”
Background
Role of Monitoring and Blunting Coping Styles in Primary Insomnia
Voss, U., Kolling, T., & Heidenreich, T. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000195881.01317.d9 · Cited by 36
“Focusing on these two coping modes, exclusively, Miller (8) developed a trait-state model of coping, proposing that (1) the beneficial effect of monitoring and blunting strategies on stress reduction depend on the control contingencies of a specific situation and (2) many individuals rigidly resort to either monitorin…”
BackgroundMethod
Epidemiology of Insomnia: from Adolescence to Old Age
Johnson, E. O. (2006) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2006.06.006 · Cited by 36
Self-reported nonrestorative sleep in fibromyalgia – relationship to impairments of body functions, personal function factors, and quality of life
Börsbo, B., Liedberg, G., & Björk, M. (2015) · Journal of Pain Research · doi:10.2147/jpr.s86611 · Cited by 35
“42 Thus, not all people experiencing poor sleep try to solve their problem by using hypnotic drugs or are not offered medication by their physician.”
Days-Out-of-Role Associated With Insomnia and Comorbid Conditions in the America Insomnia Survey
Hajak, G., Petukhova, M. V., Lakoma, M. D., Coulouvrat, C., Roth, T. G., Sampson, N. A., Shahly, V., Shillington, A. C., Stephenson, J. J., Walsh, J. K., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.08.010 · Cited by 35
“Although a few tudies have established associations of insomnia with impairents that persisted after adjusting for comorbidity (18,20,24), these results are limited by suboptimal assessments of insomnia and comorbid conditions.”
Can Sleep Be Bad For You? Can Insomnia Be Good?
Buysse, D. J., & Ganguli, M. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.2.137 · Cited by 33
Pharmacologic treatment of fibromyalgia
Baker, K., & Barkhuizen, A. (2005) · Current Pain and Headache Reports · doi:10.1007/s11916-005-0003-x · Cited by 35
Psychosocial work stressors for insomnia: a prospective study on 50–60-year-old adults in the working population
Jansson‐Fröjmark, M., Lundqvist, D., Lundqvist, N., & Linton, S. J. (2007) · International Journal of Behavioral Medicine · doi:10.1007/bf03002996 · Cited by 34
Predictors of Sleep Disturbances in Operation Iraqi Freedom/Operation Enduring Freedom Veterans Reporting a Trauma
Gellis, L. A., Gehrman, P., Mavandadi, S., & Oslin, D. W. (2010) · Military Medicine · doi:10.7205/milmed-d-09-00123 · Cited by 35
Chronic Insomnia and Health Care Utilization in Young Adults
Bramoweth, A. D., & Taylor, D. J. (2012) · Behavioral Sleep Medicine · doi:10.1080/15402002.2011.587067 · Cited by 34
“Simon and VonKorff (1997) noted that, ―Attempts to disentangle these relationships encounter difficulty at both the measurement or”
Background
Adverse effects of temazepam in older adults with chronic insomnia
Morin, C. M., Bastien, C., Brink, D., & Brown, T. R. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.454 · Cited by 33
“…increases with aging and older adults complain primarily of frequent or prolonged nocturnal awakenings, early morning awakenings with an inability to return to sleep, or a combination of these difficulties (Bliwise, 1993; Ford and Kamerow, 1989; Mellinger et al., 1985; Simon and VonKorff, 1997).”
Background
A randomized controlled trial comparing guided internet-based multi-component treatment and internet-based guided sleep restriction treatment to care as usual in insomnia
Krieger, T., Urech, A., Duss, S. B., Blättler, L. T., Schmitt, W. J., Gast, H., Bassetti, C. L., & Berger, T. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.01.045 · Cited by 36
Insomnia-related comorbidities and economic costs among a commercially insured population in the United States
Pollack, M. F., Seal, B. S., Joish, V. N., & Cziraky, M. J. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903035505 · Cited by 33
“The data files used for this study were derived from two Medstat MarketScan research databases: (1) the Commercial Claims and Encounters Database (CCED), and (2) the Health and Productivity Management (HPM) Subset Database from 2000 to 2004.”
Method
Insomnia - treatment pathways, costs and quality of life
Scott, G., Scott, H. M., O’Keeffe, K., & Gander, P. H. (2011) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-9-10 · Cited by 33
“The differences in direct health costs between these two groups ranged from 5% to 200% (mean 57%, median 24%) [14-20].”
Background
Tratamento não farmacológico para a insônia crônica
Passos, G. S., Tufik, S., Santana, M. G. D., Poyares, D., & Mello, M. T. D. (2007) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462006005000045 · Cited by 32
Factors Associated with Poor Sleep Quality in Primary Care
Kang, J.-M., Lee, J. A., Jang, J.-W., Kim, Y. S., & Sunwoo, S. (2013) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2013.34.2.107 · Cited by 32
GABA A Receptors Are Well Preserved in the Hippocampus of Aged Mice
Palpagama, T. H., Sagniez, M., Kim, S., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2019) · eNeuro · doi:10.1523/eneuro.0496-18.2019 · Cited by 35
“Benzodiazepines are commonly used as therapeutic agents for the treatment of anxiety (Vajda and Burrows, 1983), depression (Johnson, 1985), and insomnia (Simon and VonKorff, 1997).”
Background
Effect of Valerian Extract Preparation (BIM) on the Sleep-Wake Cycle in Rats
Tokunaga, S., Takeda, Y., Niimoto, T., Nishida, N., Kubo, T., Ohno, T., Matsuura, Y., Kawahara, Y., Shinomiya, K., & Kamei, C. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.363 · Cited by 32
Withdrawal Reactions after Stopping Hypnotics in Patients with Insomnia
LADER, M. H. (1998) · CNS Drugs · doi:10.2165/00023210-199810060-00004 · Cited by 32
The prevalence of sleep problems and their socio-demographic and clinical correlates in young Chinese rural residents.
Chiu, H., Xiang, Y., Dai, J., Chan, S., Leung, T., Yu, X., Hou, Z.-J., Ungvari, G., & Caine, E. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.03.050 · Cited by 37
“It is an important public health challenge due to its association with poorer overall health, impaired quality of life, and greater use of general medical services (Simon and VonKorff, 1997).”
Background
Energetic and Cell Membrane Metabolic Products in Patients with Primary Insomnia: A 31-Phosphorus Magnetic Resonance Spectroscopy Study at 4 Tesla
Harper, D. G., Plante, D. T., Jensen, J. E., Ravichandran, C. T., Buxton, O. M., Benson, K. L., O'Connor, S. P., Renshaw, P. F., & Winkelman, J. W. (2013) · SLEEP · doi:10.5665/sleep.2530 · Cited by 31
Prevalence of insomnia and its impact on daily function amongst Malaysian primary care patients
Hassan, Z. A., Mazza, D., & Teng, C. L. (2012) · Asia Pacific Family Medicine · doi:10.1186/1447-056x-11-9 · Cited by 31
“Studies conducted in Western settings have reported that primary care populations have a higher prevalence of insomnia (64-69%) than the general population [8-10].”
BackgroundInfluential
Functional and Economic Impact of Sleep Loss and Sleep-Related Disorders
Colten, H. R., & Altevogt, B. M. (2006) · Cited by 31
Clinical Pharmacology of Sleep
Pandi-Perumal, S. R., & Monti, J. M. (2006) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7440-3 · Cited by 31

Authors: Simon, G. E., & VonKorff, M.
Affiliations: Group Health Cooperative (US)
ORCID: Gregory E. Simon
Venue: American Journal of Psychiatry
Publisher: American Psychiatric Association Publishing
Published: 1997-10-01
Volume: 154
Issue: 10
Pages: 1417-1423
ISSN: 0002-953X (ISSN-L)
1535-7228
DOI: 10.1176/ajp.154.10.1417
OpenAlex: W1273834102
Cited by: 694
References: 29
Citations by year: 2026: 7 · 2025: 9 · 2024: 8 · 2023: 12 · 2022: 30 · 2021: 9 · 2020: 18 · 2019: 18 · 2018: 13 · 2017: 23 · 2016: 17 · 2015: 20 · 2014: 36 · 2013: 31 · 2012: 44
FWCI: 13.33
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (1r03mh047765-01)
National Institute of Mental Health (MH-47765)
Topics: Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords: insomnia, prevalence, functional disability, disability, health care utilization, psychotropic drug use, benzodiazepines, antidepressants, depressive disorders, chronic disease, productivity loss, primary care patients, health maintenance organizations
MeSH terms: Adult, Antidepressive Agents, Chronic Disease, Disability Evaluation, Female, Follow-Up Studies, Health Maintenance Organizations, Health Status, Humans, Sleep Initiation and Maintenance Disorders, Male, Primary Health Care, Psychiatric Status Rating Scales, Psychotropic Drugs, Severity of Illness Index, Telephone, Comorbidity, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevalence, burden, and treatment of insomnia in primary care

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks